Corcept Therapeutics specializes in the research and development of cortisol modulators, focusing on selective glucocorticoid receptor antagonists that regulate cortisol levels. We are dedicated to unlocking new treatment avenues for serious diseases across various fields, including endocrine disorders, oncology, and metabolic conditions. With a strong pipeline of innovative therapies and FDA-approved products, we aim to fundamentally change how these conditions are managed.
